Presence of fetal DNA in maternal plasma and serum

BACKGROUND The potential use of plasma and serum for molecular diagnosis has generated interest. Tumour DNA has been found in 'the plasma and serum of cancer patients, and molecular analysis has been done on this material. We investigated the equivalent condition in pregnancy-that is, whether fetal DNA is present in maternal plasma and serum. METHODS We used a rapid-boiling method to extract DNA from plasma and serum. DNA from plasma, serum, and nucleated blood cells from 43 pregnant women underwent a sensitive Y-PCR assay to detect circulating male fetal DNA from women bearing male fetuses. FINDINGS Fetus-derived Y sequences were detected in 24 (80%) of the 30 maternal plasma samples, and in 21 (70%) of the 30 maternal serum samples, from women bearing male fetuses. These results were obtained with only 10 microL of the samples. When DNA from nucleated blood cells extracted from a similar volume of blood was used, only five (17%) of the 30 samples gave a positive Y signal. None of the 13 women bearing female fetuses, and none of the ten non-pregnant control women, had positive results for plasma, serum or nucleated blood cells. INTERPRETATION Our finding of circulating fetal DNA in maternal plasma may have implications for non-invasive prenatal diagnosis, and for improving our understanding of the fetomaternal relationship.

[1]  G. Saglio,et al.  Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood. , 1990, Blood.

[2]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[3]  M. Sampietro,et al.  Detection of single-copy fetal DNA sequence from maternal blood , 1990, The Lancet.

[4]  J. Simpson,et al.  Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. , 1993, JAMA.

[5]  K. Klinger,et al.  FETAL CELL QUANTITATION IN MATERNAL BLOOD SAMPLES FROM NORMAL AND ANEUPLOID PREGNANCIES. • 838 , 1996, Pediatric Research.

[6]  M. Stroun,et al.  Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.

[7]  I. Mackenzie,et al.  Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers , 1993, The Lancet.

[8]  Y. Kan,et al.  Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood , 1996, Nature Genetics.

[9]  I. Sargent,et al.  Two-way cell traffic between mother and fetus: biologic and clinical implications. , 1996, Blood.

[10]  K. Fleming,et al.  PRENATAL SEX DETERMINATION BY DNA AMPLIFICATION FROM MATERNAL PERIPHERAL BLOOD , 1989, The Lancet.

[11]  C. Rodeck,et al.  Extraction of DNA from amniotic fluid cells for the early prenatal diagnosis of genetic disease , 1991, Prenatal diagnosis.

[12]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[13]  H. Mulcahy,et al.  Cancer and mutant DNA in blood plasma , 1996, The Lancet.

[14]  S. Pestka,et al.  Amplification of specific gene products from human serum. , 1993, Genetic analysis, techniques and applications.

[15]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.